“Global Personalized Cancer Vaccine Market Opportunity and Clinical Innovation Trend Outlook 2024” Report Highlights:
-
General Working Mechanism of Personalized Cancer Vaccine
-
Relevance of Biomarkers In Personalized Vaccines
-
Developmental Cost Analysis of a Personalized Cancer Vaccine
-
Advancements in the Personalized Cancer Vaccine
-
Personalized Cancer Vaccine Market Analysis by Cancer
Download Report:
https://www.kuickresearch.com/report-global-personalized-cancer-vaccine-market-opportunity-and-clinical-innovation-trend-outlook-2024.php
Report TOC
1. Personalized Cancer Vaccine: Promising Cancer Therapeutics of the Future
1.1 The Possibility of a Cancer Vaccine
1.2 Cancer Vaccines – An Insight into its Current Clinical Status
2. General Working Mechanism of Personalized Cancer Vaccine
2.1 Entities of A personalized Cancer Vaccine and Their Respective Roles
2.1.1 Tumor Neo – Antigens
2.1.2 Human Leukocyte Antigen
2.2 Personalized Cancer Vaccine in Action
2.3 Pharmacogenomics towards Genomic Polymorphism
2.4 Somatic Mutations in Cancer Pharmacogenomics
3. Relevance of Biomarkers In Personalized Vaccines
3.1 Pharmacogenomic Biomarkers
3.2 Prognostic and Predictive Biomarkers
3.3 Immune Checkpoint Biomarkers
4. Manufacturing Process and Cost Analysis of a Personalized Cancer Vaccine
4.1 Pre – Manufacturing Cost Analysis
4.2 Manufacturing Cost Analysis of Personalized Cancer Vaccine
4.2.1 Capital Cost
4.2.2 Cost of Raw Materials
4.2.3 Annual Cost of Personnel Involved in Cancer Vaccine Manufacture
4.2.4 Factory and Administrative Overheads
4.2.5 Filling and Packaging
4.3 Personalized Cancer Vaccine Cost per Patient
5. Current Market Trends and Advancements in the Personalized Cancer Vaccine Segment
5.1 Breakthrough Research Improving the Outcome of Future Personalized Cancer Vaccine
5.2 Rising Investments in the Personalized Cancer Vaccine Market
5.3 Use of mRNA for the Development of Personalized Cancer Vaccine
5.4 Collaborations and Ventures Ensure Stable Funding to the Personalized Cancer Vaccine Market
5.5 Advancement in DNA Sequencing Technology to Drive the Personalized Cancer Vaccine Market
6. Global – Personalized Cancer Vaccine Market Analysis by Cancer Type
6.1 Melanoma
6.2 Lung Cancer
6.3 Breast Cancer
6.4 Colorectal Cancer
6.5 Leukemia
6.6 Prostate Cancer
6.7 Cervical Cancer
6.8 Glioblastoma (Brain Tumor)
7. New Avenues and Opportunities for Personalized Cancer Vaccine Development
7.1 Commercial Insights into the Personalized Cancer Vaccine Pipeline
7.2 Opportunities in the Emerging Market
8. Porter’s Five Force Analysis of the Personalized Cancer Vaccine Market
8.1 Bargaining Power of Suppliers
8.2 Bargaining Power of Buyer
8.3 Threats of Substitute Products
8.4 Threat of New Entrants
8.5 Rivalry Among the Existing Competitors
9. Driving Factors of the Personalized Cancer Vaccine Market
9.1 Increasing Need for Personalized Cancer Vaccine Production
9.2 Alarming Increase in the Number of Cancer Incidences
9.3 Cancer Heterogenetic Environment
9.4 High Level of Specificity
9.5 Assistance from Government
9.6 Improvement in Genome Sequencing Techniques
9.7 Robust Clinical Pipeline Under Development
10. Major Challenges to the Personalized Cancer Vaccine Market
10.1 Scientific and Technical Challenges in Developing a Personalized Cancer Vaccine
10.2 Commercialization Challenges
11. Global Personalized Cancer Vaccine Market Future Outlook
12. Competitive Landscape
12.1 Advaxis Inc.
12.2 Avax Technologies
12.3 BioNtech AG
12.4 Celldex
12.5 CureVac AG
12.6 Genetech
12.7 Genocea
12.8 Gristone Oncology
12.9 ISA Pharmaceuticals
12.10 Merck
12.11 Moderna Therapeutics
12.12 Neon Therapeutics
12.13 Personalise
Contact:
Neeraj Chawla
Research Head
neeraj@kuickresearch.com
+91-11-47067990
